Manager | non-line manager | Asset Marketing Group 1, Cardio Renal Metabolism Marketing

Role Summary:

  • Drive the robust execution of brand and launch strategies, translating high-level planning into impactful market development initiatives.
  • Spearhead relationship-building with Key External Experts (KEEs) and regulatory authorities to advocate for optimal patient care and shape the clinical landscape.
  • Operational accountability for processes and activities with significant impact on revenue generation and cost.

 

Key Job Accountabilities:

1. Strategy Comprehension

  • Understand and internalize global strategy and local strategy into tangible execution strategies.
  • Identify the key business driver among patient flows, disease maps.
  • Transition the assets to the launch team and help in launch excellence preparation.

2. Customer Centric Execution

  • Be the champion for Voice of Customer, expert of the product
  • Ideate the innovative initiatives for market development and value maximization.
  • Ensure the brand team and self-operate within our compliance policies.

3. KEE & Authority Engagement

  • Travel into the field to build and nurture long-term, strategic partnerships with KEEs and relevant healthcare authorities.
  • Engage in strategic advocacy and scientific exchange with key stakeholders to inform and shape future clinical guidelines and treatment protocols.
  • Actively listen to on-the-ground HCP insights to continuously inform market development tactics and identify emerging clinical trends.

 

Critical Qualifications:

Must have:

  • Have 5+ years of pharmaceutical marketing experience.
  • Native equivalent in Japanese, Business communication in English.
  • A proven relationship-builder with a strong track record in KEE management, authority engagement, and shaping clinical guidelines/pathways.
  • Be an individual contributor and have the ability to interface independently and effectively with Japan and global leadership team.

Nice to have:

  • Experienced and knowledgeable in the CKD (Chronic Kidney Disease) and CHF (Congestive Heart Failure) therapeutic arenas.
  • New product launch experience